Drug firms use legal loopholes to safeguard brand namesBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7257.320/b (Published 05 August 2000) Cite this as: BMJ 2000;321:320
- Scott Gottlieb
- New York
Drug companies are using legal loopholes to extend patents for their most lucrative brand name products and delay the entry of cheaper generics on to the market, according to a report from the National Institute for Health Care Management.
Intellectual property protections enacted over the past two decades have increased the average patent …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial